eli lilly. e drug is under review for type-two diabetes with the fda they were looking at the drug for weight loss. they found it immemet the goalsn the study. the weight loss they showed increased with the dose at the highest dose it led to 23% average weight loss over the course of the study. that is up from 16% on the low dose compared to 2.5% for placebo. they said this is the first time the drug delivered more than 20% weight loss on average in the study. the events looks like gi issues which were mild to moderate. obesity is a space that drugmakers have been working on for decades. bank of america is estimates the market could be big for lilly. $6.4 billion in sales for the drug in obesity alone. of course, at the fda for type-two diabetes. we are seeing this move down the line andrew >> fascinating meg, thank you we will see you later this hour when merck reports tune in for the interview with eli lilly ceo david ricks. joe. >> did you do the math can you imagine? if i lost 23%, i would go

what do you think about this pill or what eli lilly is saying? >> can you hear us?r. tell us about this pill. >> 1, 2, 3, 4, 5. you're not hearing us, are you? >> yes, i am, i am hearing you. >> neil: okay. great. it's not your fault. this pill, is it really up to doing all it says, 22% of your body weight? all right. here's what we're going to do. we'll take a quick break here. the company says this. the gist of it, yes, it will. tested over 1,000 individual. some say 2,000, those that had bmis in excess of 30, that is a body mass index and it worked for them. it was especially beneficial to diabetics and that it was able to lower key levels that made them diabetics in the first place. it gets in the weeds here. starts as an injection. no word on the cost of this or who would be eligible for this or whether medicare would cover any of this. it is a start. now, i'm told as well that other companies in the path have had pills that claim to do magical things and there's a good many pills 0 on the market today that suppress your appetite. but all of them have been foun

it is difficult to find them now. >> sean: you actually can get eli lilly but you have to search higherge service that does this. >> unless you are incredibly high risk or symptom addict, i don't think treating everybody before they get symptoms is a good idea. i do think fauci's nonsense over whether the pandemic has ended or not, when you see him come out, he basically has said courts shouldn't be involved with limiting his power, what he is saying basically as he is against individual choice, he is against american freedoms to choose their own medicine, to choose their treatment, so this is a man who is against everything that america stands for. he thinks that his edicts should stand, no court or constitution should review his edicts and no individual person should get the choice to make it. but if you look at the airport, i was in the airport this week, everybody is all smiles and 97% of the people at least are not wearing a mask because they have made the judgment that they are not at risk for covid. >> sean: well, it's pretty amazing, and also, they have been wrong the whole wa

in focus, reports on unemployment and first quarter gdp, earnings from caterpillar, eli lilly, mcdonald'su can now request google remove personal information from search results including phone numbers, email and physical addresses. you can also have google remove log-in credentials if they pop up in results. previously the company limited to personal circumstances such as bank and credit card details. google will still review requests to ensure they're legitimate and won't remove references part of a public record such as a politician's office number. a new study from bestcolleges.com states the best places to live. georgia tops the list thanks to a diverse population and low cost of living. google, apple and microsoft are expanding in atlanta. virginia is second thanks to high wages and large number of job postings. maryland, north carolina and california round out the top five. back to you. >> a lot of those other places are so much more affordable than the bay area. >> very much more affordable. >> we've learned how much we can do from home. >> thanks, sylvana. >>> discrimination accu

eli lilly says it has it and it's ready. now are you?n average of seven hundred and thirty dollars. (customer) that's something. (burke) get a whole lot of something with farmers. ♪we are farmers.bum-pa-dum, bum-bum-bum-bum♪ ♪ neil: all right, well, you know -- you know me, i try to multitask, and i work out a lot, that's just what i do, but apparently this might be a waste of time in that if you're slightly overweight, and i think i may be slightly overweight, eli lilly might have the miracle cure for you with. it's a pill, it'll start out as an injection, no indications medicare will pay for this or other government insurance companies or entities will pick up the tab, but it is promising in terms of the results. that it can lower your body mass and lead to to 22% weight reduction in those who take it. let's get the read from dr. jeanette nesheiwat. does this mean we can skip the whole diet and and exercise thing? >> hey, neil, we wish we could do that, but, no. exercise, activity, making sure you're getting enough fiber, fruits and ve

guy, what do you say >> absolutely, mel healthcare has been, look at some of these names, eli lilly within a whisper of an all-time high bristol my, .i.ay meyers breaki. you stick with the medical device and those things and energy as well i know we had the sell-off of the top of the economy energy is getting its giddy up as well, healthcare energy, stick with it. >> you have to go what is safe in this marketplace. as i said, my premise is we don't know what the fed is truly going to do. so they have been extremely transparent. now people, including myself are saying, they can't do what they say they've going to do. so they have become the most transparent they have ever been, yet, they are opaque to me no other thing will happen with the balance sheet runoff is it a cut, 25, 50? 75 basis points? no one knows to buy the's point, you got to go with safety, with healthcare. adv, karen's place, it's up 30% year-to-date now. >> jeff, every time you come to the show, you bring a great chart. you got another one, this is leak the table we'll let that go. what is it >> listen, i'm simple-minded,

. >>> surprisingly good results for an experimental weight loss drug are driving up eli lilly sharespants getting the highest dose, lost more on average than 20% of their body weight, about 50 pounds per person lily also posted strong quarterly results. >>> activist hedge fund elliott management has invested a 3% stake. pushing for the oil company to review its business strategy and return more capital to shareholders s suncor stock is up 8% on the day. >>> meta shares on the best pace since 2016, but only trading back to where it was a week ago. it's been months of tough trading. make santoli has more on the long-term picture, and you can see where the stock began to collapse. >> a severe break of a long-term trend. in three weeks it's ten years since the facebook ipo this is the entire history of facebook as a stock. now meta, of course, what you'll see here, a long scale, all percentage moves are portrayed as equals, going from 100 to 200 is the same distance as 200 to 400. it evens it out. what's fascinating it was riding this trend line all the way up to a trillion dollar valuat

a eli lilly's version and merck's version works best on b.a. two.ne has easy aspect to it. ron desantis opened monoclonal antibody centers and give it to floridians that wanted it for free until joe biden finally started rationing it. why did we take the one therapeutic that every doctor i talked to agrees works the best taking early. why aren't we mass-producing it? i was going to call you doctor. at doctor, senator, whichever you prefer. i would assume doctor. go ahead. >> was even worse than that it's not just production which is controlled by the government. it's also the fact that they have withdrawn. they withdrew it because it's not working in the laboratory is what they say. in the thousands of doctors across the country are saying it still appears to be working in the clinical practice. this happened in january. the first two monoclonal's because they said they weren't working in the lab. doctors were left with no treatment and they were saying that we think it still works. this is what's going on now. this is why it's going to be a very im

health care, good solid health care, best in class, best pharma company is eli lilly, lly.some patents rolling off, they have a robust pipeline. littlely should be strong position to own with research. liz: jeff, i'm looking at very volatile final four, three minutes of trade here, we're down 371 points for the dow jones industrials. it had been looking up 331. you're looking at a 600 plus swing. when you look into that, you pick broadcom, broadcom with a dividend of 2%. you invoke the words cash and flow, it looks like a real winner here. do you anticipate a recession? >> well, again, i guess we'll say it is imminent at some point, right in the future? liz: okay. >> we don't see it right now, latter part of 2023, maybe early 24, is what we're seeing in our data points. as we can see with fed chairman powell today, just that indication of a half a percent rate hike. you know, now if we're looking nine rate hikes in 2022 from the last meeting, puts us at 2 1/2% fed funds rate. liz: yeah. >> that is pushing it too far and we could, we may see recession sooner if we push, we h

now let's consider eli lilly this is a huge position for our charitable trust, which let's be clear has moved from cnbc to the old website i started. up huge for the trust. why? because when the fed started hitting thebrakes, including big pharma i could tell you that lilly is doing well because of its diabetes/weight loss drug or rolls back plaque in alzheimer's patients, but the fact is we've got a new bull market and recess-proof names that can keep putting up good numbers even in the face of a slowdown a lily is a prime example of what is working in this market. there are a lot more lilys than there are fangs. they're from the very big cohort that wins when the fed is tightening it's not just pharma take a look at the food stocks we hear about food inflation, packaging inflation, freight inflation. conagra normally would have sent the stock down 5%, right what happens the stock actually goes higher betting that conagra's inflation is running its course. call it the last inflation-addled quarter, ointerest last bad quarter we've seen the same thing happen with general mills wow, what

senator , i spend more hours than i would than anyone would probably believe helping people find the eli lilly monoclonal antibody for omicronlo, a two dy one very specific monoclonalrk antibody that they say workss the best on it and paxlovid isea nearly impossible to get a dose of. now i've been able to successfully help a couple of people, but most people that i say doctor speak very favorably of it. talk to your doctor. you might want to try this . they can't't find it anywhere. it's's nice that the vice president got it. why didn't they warp speed production of all these things? well, here's a here'sof question dok you think it's a good ideaoo for everybody in the country has no symptoms and as a positive text to take paxlovid when there's nothi enough of itnk to go around, dot you think we might want to designate that you takeou treatment when you're sick? so for example, if there's a shortage of this drugug, whicu is inexcusable, but if there is a shortage of the drug, why would we not ou give it to people at high risk who are symptomatic, someone who has no symptoms, has no business be

they say eli lilly's version and merck's version works best on vatu. here's a problem. they're not producing enough so that everybody has easy access to it. rhonda santurce open monoclonal antibody centers gave it to every floridian that wanted it for free until joe biden finally started rationing it. why we take the one therapeutic that every doctor i talked to agrees works the best taken early and why are we mass producing it? i was going to call you dr. at doctor, senator, whichever you prefer. i would assume doctor. go ahead. >> was even worse than that it's not just production which is controlled by the government. it's also the fact that they have withdrawn. they withdrew it because it's not working in the laboratory is what they say. in the thousands of doctors across the country are saying it still appears to be working in the clinical practice. this happened in january. the first two monoclonal's because they said they weren't working in the lab. doctors were left with no treatment and they were saying that we think it still works. this is what's going on now.

suzhou is a big manufacturing base, a lot of american companies with facilities there, eli lilly, nabisco and from a supplier perspective, the city of kunshan kunshan as well as taicang are big manufacturing bases for tech companies, including apple suppliers so pegatron said that it had to suspend production also compal is a company that makes the ipadfor apple and it also had to suspend operations quanta has a plant in shanghai and it said that it also had to halt production. so we're seeing a lot of impact to the taiwan tech world because of this now broadened level of restrictions around shanghai one other thing that just happened today was that, as you guys well know there have been a lot of reports and push back from the public against shanghai, which is one of the reasons, very likely, that we're seeing some of the authorities there addressing the concerns. well, the cyber watchdog now has issued a directive warning people against reporting what it considers to be illegal or false information about the covid lockdowns. so the cyber watchdog also said that it is going to call on onl

hear it for some people who aren't as thin and fit as i am that well it's a problem but anyway, eli lillyre you can lose up to 22% of your body weight. 22%, it's taken via syringe, it's a shot, i don't know how frequently you use it but based on a test study that appeared about 72 weeks dr. bob lahida is here, he's been so helpful to us and separating the craziness through the warnings through covid and doctor, you can help us out with this. i know i've heard this , doctor, before and it's not just because i'm old, but i'm old and i've heard this before. is this , what do you hear about this and is there anything to it >> well, neil, we're both pretty old, and that doesn't prevent us from trying to lose weight, particularly if you're a diabetic this drug maybe very helpful it's called terzepitide, and it has resulted and you can inject it once a week but there's also a pill form, 15- milligram form, which you can take everyday if you're conscientious and it allows you to lose upwards of a median of 25 pounds and in some cases you said 22% of your body weight will go, but what's really goo

start trading. 40 million people are overweight because of medicines, the news this morning that eli lilly'sit is a dramatic weight loss i'm on a drug for nerve pain, and you pretty much gain a pound a month from it. i go to whenever this is approve, and i can't keep taking a drug you ask me to take, you tell me i have to lose weight, i think a lot of people are on the same position. it's not like i want to be thin, but i have a medicine that's making me fat. give me this. >> we never got to merck >> i have to tell you merck is quietly back no one seems to care look at that that's a great number. i think merck is still an inexpensive stock. people tend to overlook it and shouldn't. i wish my trust owned it we own lilly, but merck -- >>> let's get to stop trading. >> sun corp, that's a very important situation. i've got hertz tonight, steve scherr, and then david foulkes with brunswick i love my whales. >>> we'll see you tonight. >> thank for you coming back and condolences. >> thank you. >>> a couple busy days >>> when we come back, jon fortt's exclusive with the ceo fortt's exclusive with t